Acrivon Therapeutics, Inc. (ACRV) vs Cognition Therapeutics, Inc. (CGTX)

Acrivon Therapeutics, Inc. and Cognition Therapeutics, Inc. are both Biotechnology companies. Acrivon Therapeutics, Inc. and Cognition Therapeutics, Inc. are of similar size ($90.9M and $90.7M). Across the 8 metrics below, Cognition Therapeutics, Inc. leads on 5 and Acrivon Therapeutics, Inc. on 3.

Valuation

Metric ACRV CGTX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.01 2.58 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.03 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (89.52%) (18.09%) (28.84%)
Free cash flow yield (72.99%) (20.77%) (23.03%)

Profitability

Metric ACRV CGTX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (64.63%) (83.76%) (57.72%)
Return on assets (57.61%) (57.33%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACRV CGTX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 15.13% 62.79% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACRV CGTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.99 7.03 4.73
Net debt to EBITDA 1.43 0.78 0.96

Dividend

Metric ACRV CGTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ACRV CGTX Biotechnology median
Market cap 90.85m 90.68m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack